Provided by Tiger Trade Technology Pte. Ltd.

John Hancock Premium Dividend Fund

12.60
-0.0100-0.08%
Post-market: 12.600.00000.00%16:10 EDT
Volume:117.89K
Turnover:1.49M
Market Cap:619.73M
PE:4.94
High:12.67
Open:12.64
Low:12.58
Close:12.61
52wk High:13.65
52wk Low:12.49
Shares:49.19M
Float Shares:49.19M
Volume Ratio:1.49
T/O Rate:0.24%
Dividend:1.02
Dividend Rate:8.10%
EPS(TTM):2.55
EPS(LYR):1.39
ROE:18.06%
ROA:2.88%
PB:0.84
PE(LYR):9.05

Loading ...

Press Release: JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

Dow Jones
·
May 20

Biofrontera Inc. Reports First Quarter 2026 Financial Results and Provides a Business Update

GlobeNewswire
·
May 14

Press Release: LogicMark, Inc. Announces Strong First Quarter 2026 Results

Dow Jones
·
May 14

Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis

GlobeNewswire
·
May 13

Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026

GlobeNewswire
·
May 09

John Hancock Premium Dividend Fund director Christine Hurtsellers acquires USD 11,989 shares

Reuters
·
May 08

Press Release: Logitech Announces Q4 and Full Fiscal Year 2026 Results

Dow Jones
·
May 06

Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2026

GlobeNewswire
·
May 05

WidePoint to Present at the LD Micro Invitational XVI on Monday, May 18, 2026 at 10:30 a.m. PDT

GlobeNewswire
·
May 05

Press Release: JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

Dow Jones
·
May 02

John Hancock Premium Dividend Fund pays monthly distribution of $0.0825 a share

Reuters
·
May 01

Press Release: Logitech Announces Date for Release of Fourth Quarter and Full-Year Financial Results for FY 2026

Dow Jones
·
Apr 08

Press Release: JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS

Dow Jones
·
Apr 02

John Hancock Premium Dividend Fund declares $0.0825 monthly distribution per share

Reuters
·
Apr 01

Biofrontera Inc. Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

GlobeNewswire
·
Mar 19

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

GlobeNewswire
·
Mar 10

Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris

GlobeNewswire
·
Mar 09